Background: Molecular testing (MT) is emerging as a potential prognostic factor that can be
available before treatment of differentiated thyroid carcinoma begins. Among patients …

The prognosis of poorly differentiated thyroid carcinomas (PDTC) defined by the Turin
criteria is variable. The aim of this study on 51 PDTC patients was to determine clinical …

Prognosis in Differentiated Thyroid Cancer (DTC) patients is excellent, but a significant
degree of overtreatment still exists because of the inability to accurately identify small patient …

Background Various prognostic factors are expected to refine the American Thyroid
Association (ATA) recurrence risk stratification for patients with papillary thyroid cancer …

Aim The aim of this study was to validate the effectiveness of delayed risk stratification (DRS)
in predicting structural progression and compare the predictive value of American Thyroid …

Objective: The primary purpose of this study was to validate the proposed modified 2009
American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with …

Background Molecular testing improves the diagnostic accuracy of thyroid cancer. Whether
specific molecular testing results are associated with tumor phenotype or provide prognostic …

Objective To validate the A merican T hyroid A ssociation (ATA) initial risk of recurrence
scheme and the M emorial S loan K ettering C ancer C enter (MSKCC) response to therapy …

Background: The concept of a dynamic risk-stratification scheme has been suggested for
individualized management of patients with papillary thyroid carcinoma (PTC). However …

Objective: To evaluate the influence of age at diagnosis on the frequency of structural
incomplete response (SIR) according to the modified risk of recurrence (RR) staging system …